C12Y 203/01043
Phosphatidylcholine-sterol o-acyltransferase , i.e. lecithin-cholesterol acyltransferase or lcat
Official title: Phosphatidylcholine-sterol O-acyltransferase (2.3.1.43), i.e. lecithin-cholesterol acyltransferase or LCAT
C12Y203/01043 (Phosphatidylcholine-sterol o-acyltransferase , i.e. lecithin-cholesterol acyltransferase or lcat) appears on 13 US grants and 21 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 21
- Assignees
- 11
- Inventors
- 37
- Latest grant
- 26 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 3 |
| 2013 | 1 | 2 |
| 2014 | 1 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 2 |
| 2020 | 2 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
By publication year.
Recent patents
- Therapeutic combinations to treat red blood cell disorders26 Nov 2024US 12,150,975 B2Hartis-Pharma SA
- Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof30 Jan 2024US 11,883,470 B2The Trustees of the University of Pennsylvania
- Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene31 Mar 2020US 10,604,755 B2CuRNA, Inc.
- Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications17 Mar 2020US 10,591,478 B2Roseman University of Health Sciences
- Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT1 May 2018US 9,957,503 B2CuRNA, Inc.
- Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof24 Oct 2024US 2024/0350595 A1The Trustees of the University of Pennsylvania
- B cells for in vivo delivery of therapeutic agents and dosages thereof23 Jun 2022US 2022/0193129 A1
- Methods of treating and protecting against cardiac disease, cardiovascular disease and related conditions and symptoms20 Aug 2020US 2020/0261549 A1Alphacore Pharma, LLC
- Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof19 Sep 2019US 2019/0282670 A1The Trustees of the University of Pennsylvania
- Therapeutic combinations to treat red blood cell disorders6 Jun 2019US 2019/0167767 A1Hartis-Pharma SA
Most cited
By later US patents
- Process of water degumming an edible oil11US 9,228,211 B2Dupont Nutrition Biosciences Aps · 2016
- Lecithin-cholesterol acyltransferase protein7US 6,498,019 B1Takeda Chemical Industries, Ltd. · 2002
- Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene2US 10,604,755 B2CuRNA, Inc. · 2020
- Murine lecithin-cholesterol acyltransferase protein1US 7,157,259 B2Takeda Pharmaceutical Company Limited · 2007
- Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA11US 9,155,754 B2CuRNA, Inc. · 2015